Arrowgrass Capital Partners (US)’s Kite Pharma, Inc. KITE Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-245,312	Closed	-$44.1M	–	605
2017 Q3	$44.1M	Buy	+245,312	New	+$34.2M	0.33%	81
2015 Q1	–	Sell	-50,977	Closed	-$2.94M	–	562
2014 Q4	$2.94M	Buy	50,977 +40,977	+410%	+$1.73M	0.05%	209
2014 Q3	$285K	Buy	+10,000	New	+$247K	0.01%	299

Arrowgrass Capital Partners (US)'s KITE Position: Q4 2017 in Review

Arrowgrass Capital Partners (US) sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 245,312 shares — an estimated $44.1M sold.

Arrowgrass Capital Partners (US) first reported a position in KITE in Q3 2014 and held it in 3 quarters. The position peaked at $44.1M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Arrowgrass Capital Partners (US) reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Arrowgrass Capital Partners (US) sold 245,312 Kite Pharma, Inc. shares in Q4 2017, an estimated $44.1M.
Arrowgrass Capital Partners (US) first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 3 quarters.
Arrowgrass Capital Partners (US)'s Kite Pharma, Inc. position peaked at $44.1M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q4 2017, filed 14 Feb 2018.